Search

everythinglearnresearchcommunity

for

Search:↓

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

CTP-543 is generally safe for treating alopecia areata.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Some chemotherapy can cause permanent hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Minoxidil helps prevent hair loss from chemotherapy in rats.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Rituximab may cause skin issues, but baricitinib can help improve them.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.